Dr. Ronan T. Swords
Claim this profileOHSU Knight Cancer Institute
Studies Acute Myeloid Leukemia
Studies Acute Myelogenous Leukemia
9 reported clinical trials
24 drugs studied
Area of expertise
1Acute Myeloid Leukemia
FLT3 positive
MLLr positive
TP53 positive
2Acute Myelogenous Leukemia
FLT3 positive
MLLr positive
TP53 positive
Affiliated Hospitals
Clinical Trials Ronan T. Swords is currently running
DISC-0974
for Myelofibrosis
This phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in subjects with myelofibrosis or myelodysplastic syndrome and anemia.
Recruiting1 award Phase 1 & 2
SNDX-5613
for Acute Leukemia
Phase 1 dose escalation will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of revumenib in participants with acute leukemia. In Phase 2, participants will be enrolled in 3 indication-specific expansion cohorts to determine the efficacy, short- and long-term safety, and tolerability of revumenib.
Recruiting1 award Phase 1 & 2
More about Ronan T. Swords
Clinical Trial Related3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ronan T. Swords has experience with
- Gilteritinib
- Venetoclax
- Azacitidine
- SNDX-5613
- Cedazuridine
- Decitabine
Breakdown of trials Ronan T. Swords has run
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Myelofibrosis
Myelodysplastic Syndrome
Myeloproliferative Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ronan T. Swords specialize in?
Ronan T. Swords focuses on Acute Myeloid Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved FLT3 positive patients, or patients who are MLLr positive.
Is Ronan T. Swords currently recruiting for clinical trials?
Yes, Ronan T. Swords is currently recruiting for 3 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Ronan T. Swords has studied deeply?
Yes, Ronan T. Swords has studied treatments such as Gilteritinib, Venetoclax, Azacitidine.
What is the best way to schedule an appointment with Ronan T. Swords?
Apply for one of the trials that Ronan T. Swords is conducting.
What is the office address of Ronan T. Swords?
The office of Ronan T. Swords is located at: OHSU Knight Cancer Institute, Portland, Oregon 97239 United States. This is the address for their practice at the OHSU Knight Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.